Summary The intrinsic sensitivity of a panel of 8 human epidermoid lung cancer xenografts to vincristine and actinomycin D has been examined and the cross-resistance patterns of the most vincristine-resistant and vincristine-sensitive tumour line were tested to a variety of other drugs, including radiation. The results demonstrate that xenograft lines derived from human lung tumours not previously treated with chemotherapy exhibit a similar general pattern of cross-resistance to the drugs vincristine, actinomycin D and adriamycin as is observed in human cell lines and in animal models selected for resistance to these drugs. It is also shown that intrinsic resistance to vincristine can be partially overcome by verapamil. This may indicate a potential role of this substance in circumventing clinically observed drug resistance.
The current treatment results of epidermoid lung cancer with cytotoxic agents are disappointing. Objectively proven tumour response can be achieved only in a small number of patients and this response is generally short-lived with little or no improvement in survival time. Neither the nature of the intrinsic resistance of tumours which do not respond to treatment nor the acquired resistance that can develop following an initial response to chemotherapy has been well characterized. Studies performed with cultured tumour cell lines and transplantable tumours selected for resistance to a single drug have shown that cross-resistance between antracyclines, actinomycins and vinca alkaloids is a common phenomenon. This phenomenon, known as multidrug resistance or pleiotropic resistance, describes the simultaneous expression of cellular resistance to a wide range of structurally unrelated drugs (Biedler & Riehm, 1970; Dano, 1972; Johnson et al., 1978; Kaye & Bowden, 1980) . Reduced cellular accumulation of the drugs as a consequence of reduced drug influx or increased drug efflux appears to account for this resistance (Beck, 1984; Riordan & Ling, 1985) . Also an increased expression of a high molecular weight, plasma membrane glycoprotein which correlates with the degree of drug resistance, could be identified in multidrug resistant cell lines (for survey see Gerlach et al., 1986) . Recently, Bell et al. (1985a, b) detected elevated levels of such membrane proteins in biopsy specimens from patients undergoing therapy for ovarian cancer and sarcomas. These findings suggest that multidrug resistant tumour cells also occur in human malignancies.
The question arises from these and other studies whether multi-drug resistance occurs only in tumours selected for resistance to a single drug or whether this phenomenon can be detected also in tumours not previously treated with chemotherapy.
In the present study we examined the intrinsic sensitivity to vincristine and actinomycin D of eight human tumour xenografts derived from epidermoid carcinomas of the lung and describe the cross-resistance patterns of a vincristineresistant and sensitive tumour line to a variety of commonly used cytotoxic agents, including radiation. (Mattern et al., 1985) .
Materials and methods

Nude
Chemotherapy and evaluation of therapeutic effect After the tumours had reached a mean diameter of 8-0 mm, the tumour-bearing mice were randomized into groups of 5-7 animals each, and treatment with the drugs (as single i.p. dose) or irradiation was started. Each drug was given at the maximum-tolerated dose to the mouse. Vincristine (VCR, Eli Lilly GmbH, Bad All agents were injected in a volume of 0.02mlg-1 body wt. Photon irradiation was performed with Co60 gamma rays (Siemens, Erlangen). Dose: 10 Gy.
The tumour growth was followed by measuring two diameters daily with calipers. The tumour weight was calculated for an ellipsoid by the formula V=(a2 x b)/2, where a is the width and b is the length in mm. This can be considered a valid estimation of weight in mg, assuming unit density (Geran et al., 1972) . The tumour sizes were standardized in the different groups by obtaining relative tumour weight (RW) calculated by the formula RW= Wx/Wo, where Wx is the mean tumour weight at any time given and Wo is the mean initial tumour weight at the start of treatment. The effect of drugs was expressed as a T/C-ratio (mean tumour size of the treated tumour/mean tumour size of control group) x 100. The lowest value was expressed as an optimal T/C (%) for each group. as a single agent in untreated patients (Bakowski & Crouch, 1983) . However, the question whether cells with a multidrug resistant phenotype are also present in situ in human tumours, is of clinical importance. There are only few clinical data regarding the emergence of multidrug-resistance and it is not clear whether cross-resistance between antibiotics, anthracyclines and vinca alkaloids is a common finding. Attempts to demonstrate the presence of multidrugresistant cells in human tumours have involved in vitro colony-forming assays in soft agar (Shoemaker et al., 1983) or assays which measure the ability of tumour cells to incorporate labelled precursors in the presence of cytotoxic drugs (Bech-Hansen et al., 1977; Volm et al., 1979).
From our study, it is clear, under the experimental conditions employed, that intrinsic resistance to vincristine is correlated with resistance to actinomycin D. Although the HXL 54 which is a well differentiated tumour with a relatively slow growth rate was found to be more resistant to all the agents tested including irradiation than, for instance, HXL 55 which is poorly differentiated and faster growing, the close relationship between the effects of vincristine and actinomycin D for the eight tumour lines supports the concept of cross-resistance between these two agents. The collateral sensitivity to alkylating agents and to antimetabolites which is often observed in a number of multidrug resistant cell lines, is also found in the resistant tumour line HXL 54 with CTX and DDP but is not so evident with 5- FU and L-PAM. Conter and Beck (1984) Kessel, 1986) . Verapamil, a calcium antagonist widely used in cardiological medicine, has been shown to be a potent modifier of vincristine resistance. In our studies, we found that verapamil (25mgkg-1) in vivo is able to increase vincristine cytotoxicity of the resistant line HXL 54, but not of the sensitive line HXL 55. These data are consistant with results of other authors who demonstrated that verapamil increased vincristine cytotoxicity in drug resistant cells in vitro (Tsuruo et al., 1981 (Tsuruo et al., , 1982 . Thus, verapamil is able to potentiate both inherent and induced resistance and this indicates a potential role for verapamil in circumventing clinically observed drug resistance.
In conclusion, our results demonstrate that xenograft lines derived from human lung tumours not previously treated with chemotherapy exhibit a similar general pattern of crossresistance to the drugs vincristine, adriamycin and actinomycin D as is observed in multidrug-resistant human cell lines and in animal tumour models and that the intrinsic resistance to vincristine can be partially overcome by verapamil.
